These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953 [TBL] [Abstract][Full Text] [Related]
26. Anticonvulsant hypersensitivity syndrome associated with Epstein-Barr virus reactivation. Chang JY; Kim SC Yonsei Med J; 2007 Apr; 48(2):317-20. PubMed ID: 17461533 [TBL] [Abstract][Full Text] [Related]
27. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583 [TBL] [Abstract][Full Text] [Related]
28. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject. Ader F; Chatellier D; Le Berre R; Morand P; Fourrier F Med Mal Infect; 2006 Jul; 36(7):396-8. PubMed ID: 16876362 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus serostatus: no difference despite aberrant patterns in athletes and control group. Pottgiesser T; Wolfarth B; Schumacher YO; Bauer G Med Sci Sports Exerc; 2006 Oct; 38(10):1782-91. PubMed ID: 17019300 [TBL] [Abstract][Full Text] [Related]
30. Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. Yoda K; Sata T; Kurata T; Aramaki H Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):185-93. PubMed ID: 10680870 [TBL] [Abstract][Full Text] [Related]
33. Histopathologic features seen in Gianotti-Crosti syndrome secondary to Epstein-Barr virus. Smith KJ; Skelton H J Am Acad Dermatol; 2000 Dec; 43(6):1076-9. PubMed ID: 11100026 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus and Astrocytoma. Freixo C; Hermouet S; Neves AM Crit Rev Oncog; 2019; 24(4):339-347. PubMed ID: 32421989 [TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection. Topp SK; Rosenfeldt V; Vestergaard H; Christiansen CB; Von Linstow ML Infect Dis (Lond); 2015; 47(12):908-14. PubMed ID: 26308113 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China. Shi T; Huang L; Chen Z; Tian J J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067 [TBL] [Abstract][Full Text] [Related]
38. Predictors of Epstein-Barr virus serostatus in young people in England. Winter JR; Taylor GS; Thomas OG; Jackson C; Lewis JEA; Stagg HR BMC Infect Dis; 2019 Nov; 19(1):1007. PubMed ID: 31779585 [TBL] [Abstract][Full Text] [Related]
39. Chronic active Epstein-Barr virus infection with cutaneous and sinus lymphoproliferation in a white female patient with 25 years' follow-up: an original case report. Picard C; Gouarin S; Comoz F; Barreau M; Verneuil L; Troussard X; Dompmartin A Br J Dermatol; 2015 Nov; 173(5):1266-70. PubMed ID: 26148205 [TBL] [Abstract][Full Text] [Related]
40. Primary Epstein-Barr virus infection shortly after primary Cytomegalovirus infection: a case report. Koyama K; Anno T; Urano T; Shigemoto R; Irie S; Kawasaki F; Kawanaka M; Kawamoto H; Kaneto H; Tomoda K J Med Case Rep; 2021 May; 15(1):257. PubMed ID: 33941264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]